Ironwood Pharmaceuticals is trading 5.9% up at $3.93 amid a broader rally in the biotech sector and positive risk-on sentiment across equity markets.
- The upward move appears driven by sector-wide optimism rather than any new company-specific catalysts or regulatory filings.
- The gain aligns with generally resilient broader equity markets and a favorable environment for biotech stocks.